Management of type 2 diabetes mellitus associated with pituitary gigantism

Omar Ali, Swati Banerjee, Daniel F. Kelly, Phillip Lee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Pituitary gigantism, a condition of endogenous growth hormone (GH) hypersecretion prior to epiphyseal closure, is a rare condition. In the adult condition of GH excess, acromegaly, the occurrence of type 2 diabetes mellitus (T2DM) and diabetic ketoacidosis (DKA) have been reported, with resolution following normalization of GH levels. We report the case of a 16-year-old male with pituitary gigantism due to a large invasive suprasellar adenoma who presented with T2DM and DKA. Despite surgical de-bulking, radiotherapy and medical treatment with cabergoline and pegvisomant, GH and insulin-like growth factor-I (IGF-I) levels remained elevated. However, the T2DM and recurrent DKA were successfully managed with metformin and low-dose glargine insulin, respectively. We review the pathophysiology of T2DM and DKA in growth hormone excess and available treatment options.

Original languageEnglish (US)
Pages (from-to)359-364
Number of pages6
JournalPituitary
Volume10
Issue number4
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Gigantism
Diabetic Ketoacidosis
Type 2 Diabetes Mellitus
Growth Hormone
Acromegaly
Metformin
Insulin-Like Growth Factor I
Adenoma
Radiotherapy
Therapeutics

Keywords

  • Diabetes mellitus
  • Diabetic ketoacidosis
  • Growth hormone
  • Metformin
  • Pituitary gigantism

ASJC Scopus subject areas

  • Endocrinology

Cite this

Management of type 2 diabetes mellitus associated with pituitary gigantism. / Ali, Omar; Banerjee, Swati; Kelly, Daniel F.; Lee, Phillip.

In: Pituitary, Vol. 10, No. 4, 12.2007, p. 359-364.

Research output: Contribution to journalArticle

Ali, Omar ; Banerjee, Swati ; Kelly, Daniel F. ; Lee, Phillip. / Management of type 2 diabetes mellitus associated with pituitary gigantism. In: Pituitary. 2007 ; Vol. 10, No. 4. pp. 359-364.
@article{5df3915b09bc447d9881b3e3c79e1f62,
title = "Management of type 2 diabetes mellitus associated with pituitary gigantism",
abstract = "Pituitary gigantism, a condition of endogenous growth hormone (GH) hypersecretion prior to epiphyseal closure, is a rare condition. In the adult condition of GH excess, acromegaly, the occurrence of type 2 diabetes mellitus (T2DM) and diabetic ketoacidosis (DKA) have been reported, with resolution following normalization of GH levels. We report the case of a 16-year-old male with pituitary gigantism due to a large invasive suprasellar adenoma who presented with T2DM and DKA. Despite surgical de-bulking, radiotherapy and medical treatment with cabergoline and pegvisomant, GH and insulin-like growth factor-I (IGF-I) levels remained elevated. However, the T2DM and recurrent DKA were successfully managed with metformin and low-dose glargine insulin, respectively. We review the pathophysiology of T2DM and DKA in growth hormone excess and available treatment options.",
keywords = "Diabetes mellitus, Diabetic ketoacidosis, Growth hormone, Metformin, Pituitary gigantism",
author = "Omar Ali and Swati Banerjee and Kelly, {Daniel F.} and Phillip Lee",
year = "2007",
month = "12",
doi = "10.1007/s11102-007-0060-8",
language = "English (US)",
volume = "10",
pages = "359--364",
journal = "Pituitary",
issn = "1386-341X",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Management of type 2 diabetes mellitus associated with pituitary gigantism

AU - Ali, Omar

AU - Banerjee, Swati

AU - Kelly, Daniel F.

AU - Lee, Phillip

PY - 2007/12

Y1 - 2007/12

N2 - Pituitary gigantism, a condition of endogenous growth hormone (GH) hypersecretion prior to epiphyseal closure, is a rare condition. In the adult condition of GH excess, acromegaly, the occurrence of type 2 diabetes mellitus (T2DM) and diabetic ketoacidosis (DKA) have been reported, with resolution following normalization of GH levels. We report the case of a 16-year-old male with pituitary gigantism due to a large invasive suprasellar adenoma who presented with T2DM and DKA. Despite surgical de-bulking, radiotherapy and medical treatment with cabergoline and pegvisomant, GH and insulin-like growth factor-I (IGF-I) levels remained elevated. However, the T2DM and recurrent DKA were successfully managed with metformin and low-dose glargine insulin, respectively. We review the pathophysiology of T2DM and DKA in growth hormone excess and available treatment options.

AB - Pituitary gigantism, a condition of endogenous growth hormone (GH) hypersecretion prior to epiphyseal closure, is a rare condition. In the adult condition of GH excess, acromegaly, the occurrence of type 2 diabetes mellitus (T2DM) and diabetic ketoacidosis (DKA) have been reported, with resolution following normalization of GH levels. We report the case of a 16-year-old male with pituitary gigantism due to a large invasive suprasellar adenoma who presented with T2DM and DKA. Despite surgical de-bulking, radiotherapy and medical treatment with cabergoline and pegvisomant, GH and insulin-like growth factor-I (IGF-I) levels remained elevated. However, the T2DM and recurrent DKA were successfully managed with metformin and low-dose glargine insulin, respectively. We review the pathophysiology of T2DM and DKA in growth hormone excess and available treatment options.

KW - Diabetes mellitus

KW - Diabetic ketoacidosis

KW - Growth hormone

KW - Metformin

KW - Pituitary gigantism

UR - http://www.scopus.com/inward/record.url?scp=36249004283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36249004283&partnerID=8YFLogxK

U2 - 10.1007/s11102-007-0060-8

DO - 10.1007/s11102-007-0060-8

M3 - Article

C2 - 17629784

AN - SCOPUS:36249004283

VL - 10

SP - 359

EP - 364

JO - Pituitary

JF - Pituitary

SN - 1386-341X

IS - 4

ER -